STEDIVAZE

Swiss trademark · 536788 · Word mark · Deleted

Register entry

Registration number
536788
Application number
55644/2005
Status
Deleted
Type
Word mark
Filed
Jul 8, 2005
Registered
Aug 18, 2005
Published
Sep 1, 2005
Deleted
Jan 31, 2026
Reason
Not renewed
Language of procedure
German
Source
Swissreg

Goods and services

Pharmaceuticals

Pharmazeutische Präparate für die Behandlung und die Prävention von Diabetes, Inkontinenz, Herz-Kreislauf-Erkrankungen, Erkrankungen und Störungen des zentralen Nervensystems, Schlaganfall, Krebs, Entzündungen und entzündliche Erkrankungen, Atemwege- und Infektions-Erkrankungen, Erkrankungen des Auto-Immun-Systems, Abstossung von festen Organtransplantaten; pharmazeutische Präparate, nämlich, Antibiotika, Erzeugnisse gegen Pilze und Immunsuppressiva; diagnostische Bild- und Ultraschall erzeugende Kontrastmittel; pharmazeutische Präparate für diagnostische pharmazeutische Produkte.

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jan 31, 2026

    Deleted, not renewed

    Status of protective title
    Active → Cancelled
    Cancellation date
    31.01.2026
    Cause for cancellation
    Cancellation due to non-renewal

    Published in Swissreg on 31.01.2026

  2. Dec 14, 2023

    Agent’s address changed

    Representative
    E. Blum & Co. AG, Patent- und Markenanwälte VSP, Vorderberg 11, 8044 Zürich → E. Blum & Co. AG, Hofwiesenstrasse 349, 8050 Zürich

    Published in Swissreg on 14.12.2023

  3. May 27, 2015

    Renewed

    Published in Swissreg on 27.05.2015

  4. Aug 2, 2011

    Transferred

    Owner
    Trovis Pharmaceuticals LLC, Five Science Park, New Haven, CT 06511, USA → Forest Laboratories, Inc., 909 Third Avenue, 23rd Floor, New York, NY 10022-4731, USA

    Published in Swissreg on 02.08.2011

  5. Mar 31, 2011

    Transferred

    Owner
    Adenosine Therapeutics LLC, P.O. Box 4362, Charlottesville, VA 22905, USA → PGx Health, LLC, Five Science Park, New Haven CT 06511, USA
    Representative
    E. Blum & Co. AG, Patent- und Markenanwälte VSP, Vorderberg 11, 8044 Zürich (removed)

    Published in Swissreg on 31.03.2011

  6. Mar 31, 2011

    Holder’s address changed

    Owner
    PGx Health, LLC, Five Science Park, New Haven CT 06511, USA → Trovis Pharmaceuticals LLC, Five Science Park, New Haven, CT 06511, USA

    Published in Swissreg on 31.03.2011

  7. Mar 31, 2011

    Agent entered

    Representative
    E. Blum & Co. AG, Patent- und Markenanwälte VSP, Vorderberg 11, 8044 Zürich

    Published in Swissreg on 31.03.2011

  8. Sep 3, 2007

    Transferred

    Owner
    Bristol-Myers Squibb Medical Imaging, Inc., 345 Park Avenue, New York N.Y. 10154, USA → Adenosine Therapeutics LLC, P.O. Box 4362, Charlottesville, VA 22905, USA
    Representative
    E. Blum & Co., Patentanwälte VSP, Vorderberg 11, 8044 Zürich → E. Blum & Co. AG, Patent- und Markenanwälte VSP, Vorderberg 11, 8044 Zürich

    Published in the SOGC no. 169 of 03.09.2007

1 earlier entry
  1. Sep 1, 2005

    Registered

    Published in the SOGC no. 169 of 01.09.2005

Parties

The register names each party by name and address. A party is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.